Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2

The severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) has resulted in almost 28 million cases of COVID-19 (Corona virus disease-2019) and more than 900000 deaths worldwide since December 2019. In the absence of effective antiviral therapy and vaccine, treatment of COVID-19 is largely sym...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Pharmacol
Main Authors: Kaur, Upinder, Acharya, Kumudini, Mondal, Ritwick, Singh, Amit, Saso, Luciano, Chakrabarti, Sasanka, Chakrabarti, Sankha Shubhra
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier B.V. 2020
Assuntos:
Full Length Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485553/
https://ncbi.nlm.nih.gov/pubmed/32926917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173545
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados